Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma.
Conditions: Advanced Hepatocellular Carcinoma Interventions: Drug: TQB2223 injection; Drug: Penpulimab Injection Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Chia | Hepatocellular Carcinoma | Liver Cancer | Research | Study